{"prompt": "['IRB Approved', '9984', 'Document Release Date: 03/25/2021', 'Clinical Study Protocol', 'Drug Substance Olaparib (AZD2281, KU-0059436); Testosterone', 'Consortium Study Number 9984', 'Edition Number 1.6', 'Date February 24, 2021', 'Appendix 4:', 'Quality of Life Surveys: FACT-P and IIEF', 'References', 'Esper P, Mo F, Chodak G et al. Measuring quality of life in men with prostate cancer using', 'the functional assessment of cancer therapy-prostate instrument. Urology 1997; 50: 920-928.', 'Rosen RC, Riley A, Wagner G et al. The international index of erectile function (IIEF): a', 'multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830.', '92(93)', 'Printed on 3/25/202']['IRB Approved', '9984', 'Document Release Date: 03/25/2021', 'Clinical Study Protocol', 'Drug Substance Olaparib (AZD2281, KU-0059436); Testosterone', 'Consortium Study Number 9984', 'Edition Number 1.6', 'Date February 24, 2021', 'Appendix 5:', 'DNA Damage Repair Pathway Genes of Interest', 'This study will require that 50% of enrolled subjects have homozygous deletions, deleterious', 'mutations, or both in one or more of the DNA damage repair (DDR) genes (i.e. DDR', 'deficiency). A list of genes previously shown to associate with response to olaparib is below.', 'Given that our understanding of genomic factors that may predict response to olaparib is', 'evolving, additional alterations in genes associated directly or indirectly in homologous', \"recombination repair response or PARP inhibitor sensitivity may be used at the PI's\", 'discretion. The other 50% of patients must have an intact DDR pathway (i.e. no', 'mutations/deletions in these genes).', 'DDR genes of interest:', 'BRCA2', 'ATM', 'FANCA', 'CHEK2', 'BRCA1', 'PALB2', 'HDAC2', 'RAD51', 'MLH3', 'ERCC3', 'MRE11', 'NBN', 'CDK12', 'Reference', 'Mateo J, Carreira S, Sandhu S et al. DNA-Repair Defects and Olaparib in Metastatic Prostate', 'Cancer. N Engl J Med 2015; 373: 1697-1708.', '93(93)', 'Printed on 3/25/202']\n\n###\n\n", "completion": "END"}